Podcast :Using Stability Models to Predict Drug Characteristics at the End of Shelf Life - - BioPharm International

ADVERTISEMENT

Podcast :Using Stability Models to Predict Drug Characteristics at the End of Shelf Life



Peter Sprinz
PhD, Research Scientist,
Manufacturing Science & Technology—Statistics
Eli Lilly and Company

Add this Podcast feed to your media player



Using Stability Models to Predict Drug Characteristics at the End of Shelf Life

Listen to this interview with Peter Sprinz, PhD, a senior research scientist at Eli Lilly, to learn about using stability models to predict drug characteristics at the end of shelf life. Listen to hear how Lilly has implemented such models, and what they have gained by doing so.



Related Links
Characterizing the Formulation Design Space
Best Practices for Formulation and Manufacturing of Biotech Drug Products
Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients

Click here to go to the main podcast page >>>

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here